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Key points: 
- The TYM-S is a valid and reliable cognitive screening tool that quickly assesses 
several cognitive domains. 
- The TYM-S has an acceptable diagnostic utility for distinguishing cases of dementia 
from controls in a sample of Spanish-speaking elderly people. 
- The TYM-S correlates significantly with other measures of global cognitive impairment, 
executive dysfunction, dementia severity, functional capacity in activities of daily living, 
and cognitive change. 
- The TYM-S may be a convenient option for assessing cognitive complaints in different 
Spanish-speaking clinical settings instead of other widely popular measures such as the 
MMSE and ACE-R. 
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Abstract 
Objective: To develop the TYM-Spanish Version (TYM-S), a self-administered cognitive 
screening test, in a Chilean elderly sample and to estimate its psychometric properties 
and diagnostic accuracy.  
Methods: The TYM was translated into Spanish and adapted for a Chilean population to 
develop the TYM-S. Measures of global cognitive impairment and executive dysfunction 
were administered to 30 controls, 30 dementia patients, and 14 subjects with mild 
cognitive impairment (MCI). All participants’ proxies were interviewed with assessments 
of dementia severity, functionality in daily living activities, and cognitive change. 
Convergent validity and internal consistency reliability of the TYM-S were estimated. 
Cut-off points, sensitivity, and specificity were determined to test its diagnostic capacity 
for dementia or MCI. 
Results: Regarding convergent validity, the TYM-S was significantly correlated (p<.001) 
with global cognitive impairment (MMSE: r=.902; ACE-R-Ch: r=.922; MoCA: r= .923), 
executive dysfunction (FAB: r=.862), dementia severity (CDR: r=-.757), functional 
capacity (T-ADLQ: r=-.864; PFAQ: r=-.748; IADL: r=.769), and cognitive change (AD8-
Ch: r=-.700) measures. Regarding reliability, Cronbach’s α was .776. Optimum cut-off 
scores of 39 and 44 distinguished dementia cases from controls (93.1% sensitivity, 
82.2% specificity) and MCI cases from controls (85.7% sensitivity, 69% specificity), 
respectively. The extent of assistance required in the TYM-S and cognitive impairment 
were correlated. 
Conclusions: The TYM-S is a valid and reliable instrument to assess cognitive 
impairment, showing good psychometric properties and diagnostic capacity to identify 
cases of dementia in a Spanish-speaking elderly cohort. While its need for assistance 
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may be limiting, its ability to quickly assess several cognitive domains supports 
widespread clinical use. 
Page 4 of 32
http://mc.manuscriptcentral.com/gps
International Journal of Geriatric Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 5
Introduction 
Dementia is a major public health concern of the 21st century for many reasons, 
chief among these being its high psychosocial impact (Thies and Bleiler 2012). 
Prevalence of dementia increases exponentially with age, affecting approximately one in 
ten people over the age of 65 and half of people over 85 (Evans, et al. 1989; Fitzpatrick, 
et al. 2004). Thirty-six million people worldwide are estimated to suffer from dementia 
nowadays and this number is expected to triple by 2040 (Reitz, et al. 2011; Wimo and 
Prince 2010). In 2011, an estimated 60% of dementia patients lived in low- and middle-
income countries whereas by 2040, this percentage is expected to reach 71% (Prince, 
et al. 2007). 
Proper screening tools for dementia that are sufficiently sensitive, yet easily 
administered, must be developed to overcome several hurdles in early diagnosis of 
these patients (Cullen, et al. 2007; Scharre, et al. 2010; Villarejo and Puertas-Martin 
2011). A large number of brief cognitive measures exist; however, many present 
disadvantages, such as requiring too much time and qualified personnel while others are 
simply too cumbersome to administer in busy clinical settings (Boustani, et al. 2005). 
Moreover, potential drawbacks of informant-based assessments to identify early 
dementia are that patients are often assessed alone and may not have a reliable or 
accessible informant (Scharre et al. 2010). 
Three requirements for widespread use of a cognitive screening test by non-
specialists have been identified: minimal administration time, assessment of a 
reasonable range of cognitive functions, and sensitivity to mild Alzheimer’s disease (AD) 
(Brown, et al. 2009). Allowing patients to fill in a test themselves may overcome the 
paradox of thorough testing in minimal time. The Test Your Memory (TYM) (Brown et al. 
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2009) is a self-administered cognitive screening test developed to fulfill the three 
aforementioned requirements to facilitate its broad use in clinical settings. It is a valid 
and reliable instrument with very good psychometric properties to identify dementia or 
cognitive impairment. Moreover, the TYM has been shown to better detect AD 
compared to more traditional cognitive screening tests, such as the Mini-Mental State 
Examination (MMSE) and Addenbrooke’s Cognitive Examination-Revised (ACE-R) 
(Brown et al. 2009). Furthermore, the instrument has been validated in Afrikaans, 
Japanese, Chinese, and Polish populations in addition to a large cohort of unselected 
English patients from cognitive clinics (Brown et al. 2009; Hancock and Larner 2011; 
Hanyu, et al. 2011; Hou and Lee 2011; Szczesniak, et al. 2013; van Schalkwyk, et al. 
2012). 
The aim of this study was to develop the TYM-Spanish Version (TYM-S) and to 
study its psychometric properties and diagnostic utility for identifying dementia or mild 
cognitive impairment in a Chilean elderly sample. To further validate the TYM-S, its 
scores were compared to those obtained on other measures of global cognitive 
impairment, executive dysfunction, dementia severity, functional capacity, and cognitive 
change. 
 
Methods 
Development of the TYM-S 
To generate the TYM-S, the original TYM was translated into Spanish and later 
adapted for a Spanish context by a neurologist (ASC) and two psychologists (CMN, 
FHC). The resulting version was back-translated into English, showing clear consistency 
with the original instrument. Two sections of the original, Semantic Knowledge and 
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Verbal Fluency, were modified to improve their comprehension and cultural adequacy 
for Spanish speakers and the Chilean population (see Appendix 1). 
The TYM is presented on a double-sided sheet of paper with spaces for the 
patient to fill in. Its scores range from 1 to 50. The test comprises of 10 tasks assessing 
11 cognitive domains: orientation, copying (ability to copy a sentence), semantic 
knowledge (retrograde memory), calculation, verbal fluency (phonemic), abstraction 
(similarities), naming, visuospatial abilities, anterograde memory, and executive function 
(EF) or capacity to complete the test without help (Table 1). If necessary, patients can 
be assisted with any part of the test except the answers. There is no time limit. Detailed 
instructions of the TYM are described by Brown et al. (2009).  
Participants 
A convenience sample of Spanish speakers was recruited from the Cognitive 
Neurology and Dementia Unit of the Hospital del Salvador in Santiago, Chile. Inclusion 
criteria comprised of subjects 65 years old or older without conditions that could 
preclude a neuropsychological assessment (e.g. sensory disturbances such as 
visual/auditory impairments). All participants had proxies who shared relevant 
information about participants’ everyday activities and behavior, and provided informed 
consent prior to study inclusion. In cases of marked cognitive impairment where 
informed consent could be misunderstood, consent was provided by the collateral 
sources who took care of the patient. Exclusion criteria included illiteracy, debilitating 
cognitive impairment that could interfere with neuropsychological assessment, 
underlying medical or psychiatric illness that could affect cognition, and absence of a 
reliable proxy. 
The sample was divided into three groups. There were 30 control participants 
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without preexisting neurological or psychiatric disorders that could cause 
neuropsychological disturbance, 30 patients with dementia [20 with AD, 4 with 
frontotemporal dementia (FTD), 4 with dementia with Lewy bodies (DCL), 2 with 
vascular dementia (VD)], and 14 participants with amnestic or multidomain mild 
cognitive impairment (MCI). All participants had appropriate Clinical Dementia Rating 
(CDR) scale scores (controls = 0, dementia ≥ 1, MCI ≤ .5,) (Hughes, et al. 1982; Morris 
1993).  
All controls had normal cognition based on local normative data for the MMSE 
(González-Hernández, et al. 2009) and Frontal Assessment Battery (FAB) (Alegría 
2005), and were deemed cognitively normal by the neurologist. A neurologist diagnosed 
dementia and MCI based on detailed neurological, neuropsychological, laboratory, and 
neuroimaging data for each participant. The first step in diagnosing dementia was to 
determine the presence or absence of the disease using criteria in the Diagnostic and 
Statistical Manual of Mental Disorders (4th edition, text revision) (American Psychiatric 
Association 2000). If criteria were met, the specific type of dementia was specified using 
multiple diagnostic criteria: (a) National Institute of Neurological and Communicative 
Disorders and Stroke-AD and Related Disorders Association criteria for AD, (b) the 
consensus criteria for FTD diagnosis, (c) the third report of the Dementia with Lewy 
Bodies Consortium criteria for DCL, and (d) AD Diagnostic and Treatment Centers 
criteria and National Institute of Neurological Disorders and Stroke criteria for VD 
(McKeith, et al. 2005; McKhann, et al. 1984; Neary, et al. 1998; Roman, et al. 1993). 
MCI diagnosis was established according to the International Working Group on MCI 
consensus criteria (Winblad, et al. 2004). 
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The CDR scale was administered to all proxies. Afterward, the proxies were 
asked to complete a set of questionnaires including assessments of functional capacity 
and cognitive change. 
This study was approved by the Ethical and Scientific Committee of the Servicio 
de Salud Metropolitana Oriente in Santiago, Chile. 
Assessment and Materials 
To study the convergent validity of the TYM-S, global cognitive impairment was 
measured in addition to three Chilean versions of neuropsychological instruments: the 
MMSE (González-Hernández et al. 2009), the ACE-R (ACE-R-Ch) (Muñoz-Neira, et al. 
2012), and the Montreal Cognitive Assessment (MoCA) (Araneda, et al. 2013). The FAB 
was considered a global measure of executive dysfunction (Alegría 2005; Dubois, et al. 
2000). To determine if the TYM-S was a valid measure of dementia severity, the CDR 
scale assessed clinical progression and stages of dementia. Proxies also completed 
three functionality scales: the Technology-Activities of Daily Living Questionnaire (T-
ADLQ) (Munoz-Neira, et al. 2012), Pfeffer Functional Activities Questionnaire (PFAQ) 
(Pfeffer, et al. 1982), and Instrumental Activities of Daily Living (IADL) (Lawton 1988). 
The AD8-Chilean Version (AD8-Ch) was used as an indicator of cognitive change 
(Munoz, et al. 2010). 
Procedures and Statistical Analysis 
Descriptive and comparative analyses were conducted using either a one-way 
analysis of variance (ANOVA) to compare the three groups for continuous variables or 
the χ2 test for categorical variables. A multiple regression analysis evaluated which 
demographic variables were associated with TYM-S performance in the entire sample. 
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Additionally, a one-way multivariate ANOVA compared responses to TYM-S items 
across diagnostic categories. Convergent validity of the TYM-S was evaluated using 
Pearson correlation between TYM-S scores and results of the other instruments 
administered. Internal consistency was measured with Cronbach’s α, which reflects the 
average inter-item correlation and thus increases when correlations among items 
increase (Bland and Altman 1997). Two receiver operating characteristic (ROC) 
analyses were performed to determine the ability of the TYM-S and the other cognitive 
assessments to discriminate between dementia patients (CDR ≥ 1) and controls (CDR = 
0), and between MCI patients (CDR = 0.5) and controls (CDR = 0). Analyses were 
carried out to select an optimal TYM-S cut-off score, below which an individual has a 
very high chance of having dementia or MCI. The area under the curve (AUC) measured 
diagnostic utility of the TYM-S in distinguishing dementia or MCI patients from controls. 
AUC values less than perfect (1.0) were classified as having excellent (> .9), good (> 
.8), fair (> .7), or poor (> .6) utility (Gifford and Cummings 1999). All analyses were 
conducted at p < .05 (two-tailed) using the Statistical Package for the Social Sciences 
(SPSS) version 20 for Windows (IBM Corp., Armonk, NY, USA). Effect sizes (Cohen’s d 
statistic) were also calculated to determine the magnitude of group differences on the 
instrument. According to Cohen (1988), effect sizes are categorized as small (.2 to .49), 
medium (.5 to .79), or large (greater than .8). Positive effect sizes indicate lower 
performance in people with dementia and MCI compared with controls. 
 
Results 
Demographic and Clinical Data 
The total sample included 74 participants (42 men, 32 women). Table 2 
Page 10 of 32
http://mc.manuscriptcentral.com/gps
International Journal of Geriatric Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 11
summarizes their demographic characteristics and clinical profiles. No significant 
differences (p > .05) were found among groups with respect to age (F(2, 73) = 0.164, p = 
.849), years of education (F(2, 73) = 0.957, p = .389), or sex (χ
2 = 1,088, GL = 2, p = .581). 
The three groups did differ significantly in measures of global cognitive impairment 
(MMSE: F(2, 73) = 56.820; ACE-R-Ch: F(2, 73) = 74.492; MoCA: F(2, 73) = 55.702; all p’s < 
.001), executive dysfunction (FAB: F(2, 73) = 28.916, p < .001), dementia severity (CDR: 
F(2, 73) = 103.905, p < .001), functional capacity (T-ADLQ: F(2, 73) = 47.106; PFAQ: F(2, 73) 
= 48.374; IADL: F(2, 73) = 47.472; all p’s < .001), and cognitive change (AD8-Ch: F(2, 73) = 
47.915, p < .001). Details of the post-hoc analysis are specified in Table 2. Dementia 
patients performed significantly worse than MCI patients and controls while MCI patients 
performed significantly worse than controls on measures of global cognitive impairment, 
executive dysfunction, disease severity, functional capacity, and cognitive change. 
Administration of the TYM-S 
All participants completed the TYM-S with an average time of 11.28 minutes 
(range: 8-18 minutes). The three groups differed significantly in completion time (F(2, 73) = 
8.061, p < .01) and the amount of help needed with th  test (F(2, 73) = 8.061, p < .01). 
The observed assistance level in the TYM-S reached 33.3% in controls, 90% in 
dementia, and 71.43% in MCI. Performance on the TYM-S is detailed in Table 3. 
Influence of Demographic Variables on TYM-S Performance 
To determine the effects of demographic variables on TYM-S performance for all 
participants, a multiple regression analysis (Enter Method) was performed with TYM-S 
scores as dependent variables and participant-based variables (age, years of education, 
sex) as independent variables. The resulting regression model excluded age and sex as 
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important factors. Years of education had a positive effect (β coefficient = .31, p < .001) 
and explained 15% of the total variance in TYM-S scores (r2 = .150, F(2, 70) = 4.12, p = 
.009). 
Convergent Validity and Reliability of the TYM-S 
The TYM-S showed statistically significant associations with other measures of 
global cognitive impairment, executive dysfunction, dementia severity, functional 
capacity, and cognitive change (Table 4). Cronbach’s α was .776, suggesting high 
internal consistency of the 11 items of the TYM-S.  
Divergent Validity, Sensitivity, and Specificity of the TYM-S 
Table 3 summarizes the global and individual item TYM-S scores for the three 
groups. A one-way multivariate ANOVA revealed a significant multivariate main effect of 
diagnosis (Wilks’s lambda = .273, F(20, 124) = 5.662, p < .001, partial eta squared = .477, 
with a power of 1.00 to detect the effect). The three groups differed significantly in 
average TYM-S scores (F(2, 73) = 47.963, p < .001). Significant differences were found 
among controls, dementia patients, and participants with MCI for each TYM-S item 
(orientation: F(2, 73) = 34.477; copying: F(2, 73) = 5.151; semantic knowledge: F(2, 73) = 
39.824; calculation: F(2, 73) = 6.571; verbal fluency: F(2, 73) = 14.225; abstraction: F(2, 73) = 
14.631; naming: F(2, 73) = 16.621; visuospatial abilities: F(2, 73) = 28.200; anterograde 
memory: F(2, 73) = 30.121; EF: F(2, 73) = 28.134; all p’s < .001). Details of the post-hoc 
analysis are presented in Table 3. 
Results of the ROC curve analyses for the TYM-S and the other cognitive 
measures are displayed in Table 5 and Figure 1. It should be noted that the TYM-S 
distinguished between dementia patients and controls (AUC = .963) better than between 
MCI patients and controls (AUC = .826). A cut-off point of 39 was optimal for detecting 
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dementia using the TYM-S with a sensitivity of 93.1% and a specificity of 82.2% [95% CI 
(.922, 1.00)], indicating high overall diagnostic utility of the test to identify cases of 
dementia. A cut-off point of 44 discriminated MCI patients from controls and had a 
sensitivity of 85.7% and a specificity of 69% [95% CI (.697, .956)]. No significant 
differences in AUC among the TYM-S, MMSE, ACE-R-Ch, MoCA, and FAB (p > .05) 
emerged between the dementia versus control groups, as well as between the MCI 
versus control groups (Hanley and McNeil 1983). 
The standardized mean difference (Cohen’s d) for the TYM-S was 2.41 (r = .77) 
between dementia patients and controls, 1.50 (r = .60) between dementia and MCI 
patients, and 1.20 (r = .51) between MCI patients and controls. 
 
Discussion 
This study provided evidence to support the use of the TYM-S as a valid and 
reliable instrument for assessing cognitive impairment in a Chilean Spanish-speaking 
elderly cohort. In addition to its good psychometric properties, the TYM-S showed an 
acceptable diagnostic utility for identifying cases of dementia.  
Strong and statistically significant relationships found between the TYM-S and 
measures of global cognitive impairment (MMSE, ACE-R-Ch, MoCA), executive 
dysfunction (FAB), dementia severity (CDR), and functional impairment (T-ADLQ, 
PFAQ, IADL) supported its validity. These findings are consistent with previous 
validation studies of the instrument. For example, the original publication by Brown et al. 
(2009) demonstrated Pearson correlations between TYM scores and the MMSE (.55, p 
≤ .001) and ACE-R (.66, p ≤ .001) in 540 controls and 139 patients with dementia or 
amnestic MCI, supporting good convergent validity. The TYM-Japanese Version (TYM-
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J) (Hanyu et al. 2011) showed good convergent validity with the MMSE (r = .68), 
Wechsler Memory Scale-Revised (WMS-R) Logical Memory I (r = .71), AD Assessment 
Scale-Cognitive Subscale-Japanese Version (ADAS-Jcog; r = .74), and FAB (r = .66); all 
p’s < .0001. Furthermore, English and Afrikaans versions of the TYM have shown good 
associations with the MMSE (r = .455 for English-speakers, r = .747 for Afrikaans-
speakers; p < .001) (van Schalkwyk et al. 2012). Chinese (Hou and Lee 2011) and 
Polish (Szczesniak et al. 2013) validation studies have also reported acceptable 
correlations between the TYM and other cognitive measures. 
The important association between the TYM-S and measures of both global 
cognitive impairment and executive dysfunction suggests that the TYM is sensitive to 
executive disorders. This is crucial for a screening instrument since executive 
dysfunction is often the earliest and most prominent sign of certain dementias, including 
syndromes such as FTD (the behavioral variant) (Torralva, et al. 2008) and VD 
(Graham, et al. 2004; Merino and Hachinski 2008). Assessment of executive function 
contributes to early diagnosis; therefore, such tasks should be included in cognitive 
tools. Indeed, a main limitation of the MMSE as a screening instrument is its poor 
sensitivity in detecting executive dysfunction (Dubois et al. 2000).  
To the best of our knowledge, this is the first study reporting a correlation 
between performance on the TYM and MoCA, which has shown an excellent ability to 
detect dementia or MCI by assessing multiple cognitive domains (Nasreddine, et al. 
2005).  
Similar to the aforementioned Chinese study, the TYM-S was also associated 
with the CDR, a measure of dementia severity. Besides, the present study provides 
additional evidence for the validity of the TYM by showing its correlation with measures 
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of executive dysfunction (FAB), functional impairment (T-ADLQ, PFAQ, IADL scale), and 
the informant-based assessment of cognitive change (AD8-Ch). The strong correlation 
between the TYM-S and functional ability is remarkable for a cognitive screening test 
given that functional impairment or disability is an essential aspect of identifying 
dementia (Royall, et al. 2007). 
Our study found the TYM-S had high internal consistency, supporting its 
reliability. Acceptable reliability data have also been identified in other studies of the 
TYM (Brown et al. 2009; Hou and Lee 2011; Szczesniak et al. 2013; van Schalkwyk et 
al. 2012). 
The diagnostic utility of the TYM-S to distinguish cases of dementia from controls 
is supported by the AUC and its acceptable sensitivity, specificity, and Cohen’s d values. 
The small sample size of MCI patients may have interfered on the results obtained to 
discriminate these individuals from controls. In their original study, Brown et al. (2009) 
reported that a TYM cut-off score of ≤ 42 showed 93% sensitivity and 86% specificity for 
AD diagnosis. Another study of memory clinic patients proposed adjusting the cut-off to 
30 which maintained acceptable sensitivity (73%) and specificity (88%) (Hancock and 
Larner 2011). Hanyu et al. (2011) proposed two cut-off points for the TYM-J: one at 42 
or 43 with 96% sensitivity and 91% specificity to distinguish AD patients from controls 
and another at 44 or 45 with 76% sensitivity and 74% specificity to differentiate MCI 
patients from healthy controls. In that study, the AUC was significantly better for the 
TYM-J than for the MMSE, WMS-R Logical Memory I, and ADAS-Jcog. The South 
African study of 100 participants showed that both English and Afrikaans versions 
performed very well in detecting cognitive impairment (van Schalkwyk et al. 2012). 
Although the TYM-S had excellent psychometric properties and diagnostic utility for 
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identifying cognitive impairment, the ROC curve analysis suggested that it did not 
discriminate between dementia or MCI patients and controls significantly better than the 
MMSE, ACE-R-Ch, MoCA, or FAB. Nevertheless, the TYM-S has advantages as a quick 
assessment of several cognitive functions, making it a promising alternative to cognitive 
tools that are not self-administered. 
The current research reported longer completion times (range: 8-18 minutes) for 
the TYM-S than previous studies, which might be deemed too lengthy in many clinical 
settings (Tangalos, et al. 1996). Considering that TYM-S administration does not require 
the presence of a professional but only supervision by a non-professional in a separate 
waiting room, this duration is probably not a limitation. In any case, it should be 
acknowledged that the self-report format of the TYM solves the paradox of achieving 
thorough testing in minimal time (Brown et al. 2009). This feature should be especially 
useful in primary care where clinicians lack sufficient time to administer a detailed 
diagnostic interview or cognitive assessment. 
Another important point is the number of cognitively impaired participants who 
required some level of assistance with the TYM-S, which may suggest that the test is 
more suitable for controls or individuals with minimal cognitive impairment rather than 
moderate-to-severe dementias. This limitation could restrict the TYM-S as a self-
administered tool; however, the test does assess the level of help given by an examiner 
which factors into the overall result. Despite the possibility that the considerable amount 
of assistance observed may reduce the overall utility of the TYM-S, its ability to quickly 
assess several cognitive domains supports its widespread use in different clinical 
settings. 
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Our study found that TYM-S performance was not correlated with age, which may 
reflect the fact that the sample was older than 60 years. As expected, TYM-S 
performance was influenced by years of education, supporting the established notion 
that education affects cognitive outcomes (Lezak 2012). This suggests the need for 
normative data on the TYM-S that considers educational level or a normative study to 
determine a better cut-off according to educational level. 
The main limitation of this study is the use of a small convenience sample that 
could preclude a generalization of the results obtained to an unselected population. 
Indeed, Hancock and Larner (2011) have pointed out that index studies of new test 
instruments are conducted in ideal diagnostic circumstances and/or with ideal patients, 
which is not representative of day-to-day clinical practice. 
To conclude, this study found that the TYM-S is a valid and reliable instrument to 
identify cases of dementia with acceptable diagnostic utility. Future research should be 
conducted with larger samples and examine the utility of the TYM-S when studying 
participants with MCI alone. Evaluating the utility of the tool in the psychiatric population 
may also be of interest. Studies must be conducted in an unselected population of 
cognitive clinic patients or those in primary care to determine the best cut-off point of the 
TYM-S in general practice.  
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Table 1 
Items of the Test Your Memory 
 
Domain/Task Score 
Orientation 10 
Copying (Ability to Copy a 
Sentence) 
2 
Semantic Knowledge (Retrograde 
Memory) 
3 
Calculation 4 
Verbal Fluency (Phonemic) 4 
Abstraction (Similarities) 4 
Naming 5 
Visuospatial Abilities (Letter W 
and Clock Test) 
7 
Anterograde Memory (Recall of a 
Copied Sentence) 
6 
Executive Function (Capacity to 
Complete the Test Without Help)  
5 
Total 50 
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Table 2 
Demographic Characteristics and Clinical Profiles of the Sample 
 
 
Parameter Descriptive Statistics by Group Comparison 
 Control 
(n = 30) 
Dementia 
(n = 30) 
MCI 
(n = 14) 
Dementia 
vs. 
Control 
Dementia 
vs. 
MCI 
MCI 
vs. 
Control 
Age¥ 71.93 ± 7.06 72.80 ± 6.90 71.71 ± 7.16 ns ns ns 
Years of 
Education¥ 
14.00 ± 4.20 12.70 ± 3.15 12.79 ± 4.59 ns ns ns 
Sex 
%Men (n) 
%Women (n) 
 
50.00% (15) 
50.00% (15) 
 
6.30% (19) 
36.70% (11) 
 
57.10% (8) 
42.90% (6) 
ns ns ns 
TYM-S 43.93 ± 5.55 
(30-50) 
22.50 ± 11.29 
(2-42) 
36.50 ± 6.81 
(23-47) 
* * * 
MMSE 28.77 ± 1.14 
(27-30) 
20.90 ± 4.15 
(13-29) 
26.29 ± 2.13 
(22-29) 
* * * 
ACE-R-Ch 91.50 ± 6.85 
(77-100) 
59.47 ± 13.69 
(34-87) 
79.50 ± 6.95 
(68-92) 
* * * 
MoCA 25.07 ± 3.25 
(18-30) 
13.90 ± 5.17 
(5-23) 
19.93 ± 2.95 
(16-26) 
* * * 
FAB 16.00 ± 1.71 
(12-18) 
11.17 ± 3.01 
(6-17) 
14.21 ± 2.36 
(10-17) 
* * ns 
CDR scale 0.00 ± 0.00 
(0-0) 
1.67 ± 0.71 
(0.5-0.5) 
0.50 ± 0.00 
(1-3) 
* * * 
T-ADLQ 12.00 ± 10.39 
(0-36) 
46.21 ± 18.33 
(12-82) 
19.93 ± 8.54 
(9-32) 
* * * 
PFAQ 0.63 ± 1.38 
(0-6) 
13.53 ± 8.37 
(0-27) 
1.21 ± 1.53 
(0-4) 
* * ns 
IADL scale 7.40 ± 0.93 
(5-8) 
3.87 ± 1.91 
(0-7) 
7.07 ± 1.44 
(4-8) 
* * ns 
AD8-Ch¥ 1.47 ± 1.98 
(0-8) 
6.30 ± 1.95 
(2-8) 
3.29 ± 1.73 
(1-6) 
* * * 
 
 
Note. Results are expressed as M ± SD. MCI = Mild Cognitive Impairment; TYM-S = Test Your Memory-
Spanish Version; MMSE = Mini-Mental State Examination; ACE-R-Ch = Addenbrooke’s Cognitive 
Examination-Revised-Chilean Version; MoCA = Montreal Cognitive Assessment; FAB = Frontal 
Assessment Battery; CDR = Clinical Dementia Rating; T-ADLQ = Technology-Activities of Daily Living 
Questionnaire; PFAQ = Pfeffer Functional Activities Questionnaire; IADL = Instrumental Activities of Daily 
Living; AD8-Ch = Alzheimer’s Disease 8-Chilean Version. 
Chi-square test applied. All other comparisons were carried out with an ANOVA test. 
¥Tukey post hoc tests applied. All other measures were compared with Games-Howell tests. 
*p < .05. 
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Table 3 
Detailed Scores on the TYM-S 
 
Parameter Descriptive Statistics by Group Comparison 
 Control 
(n = 30) 
Dementia 
(n = 30) 
MCI 
(n = 14) 
Dementia 
vs. 
Control 
Dementia 
vs. 
MCI 
MCI 
vs. 
Control 
TYM-S 43.93 ± 5.55 22.50 ± 11.29 36.50 ± 6.81 * * * 
Orientation 9.67 ± 0.48 5.77 ± 2.71 8.57 ± 1.34 * * * 
Copying 1.80 ± 0.55 1.20 ± 0.89 1.64 ± 0.74 * * ns 
Semantic 
Knowledge 
2.90 ± 0.31 1.10 ± 1.09 2.36 ± 0.74 * * * 
Calculation 3.40 ± 0.86 2.30 ± 1.44 2.93 ± 1.14 * ns ns 
Verbal Fluency 3.57 ± 0.77 2.10 ± 1.32 2.71 ± 0.99 * ns * 
Abstraction 3.57 ± 0.77 1.97 ± 1.56 3.21 ± 0.89 * * ns 
Naming 4.70 ± 0.95 2.63 ± 1.90 4.29 ± 1.07 * * ns 
Visuospatial 
Abilities 
6.07 ± 1.34 2.53 ± 2.39 5.21 ± 1.53 * * ns 
 Letter W¥ 2.20 ± 1.13 0.70 ± 1.06 1.64 ± 1.22 * * ns 
Clock Drawing Test 3.87 ± 0.43 1.83 ± 1.62 3.57 ± 0.76 * * ns 
Anterograde 
Memory 
3.70 ± 2.09 0.30 ± 1.12 1.71 ± 1.82 * * ns 
Executive Function 4.57 ± 0.73 2.60 ± 1.25 3.86 ± 1.03 * * * 
Need for Assistance 
on the TYM-S 
No assistance 
Trivial assistance 
Minor assistance 
Moderate assistance 
Major assistance 
 
 
 
66.67% 
26.67% 
3.33% 
3.33% 
0% 
 
 
 
10% 
10% 
33.33% 
23.33% 
23.33% 
 
 
 
28.57% 
42.86% 
14.29% 
14.29% 
0% 
   
Completion Time 7.60 ± 0.75 
(range: 6.09-9.11) 
14.27 ± 0.69 
(range: 12.87-15.65) 
11.51 ± 0.95 
(range: 9.6-13.42) 
   
 
 
Note. Results are expressed as M ± SD. MCI = Mild Cognitive Impairment; TYM-S = Test Your Memory-
Spanish Version. 
¥Tukey post hoc tests applied. All other measures were compared with Games-Howell tests. 
*p < .05. 
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Table 4 
Convergent Validity of the TYM-S 
 
Assessment Instrument TYM-S 
Global 
Cognitive 
Impairment 
MMSE .902 
ACE-R-Ch .922  
MoCA .923  
Executive 
Dysfunction 
FAB .862  
Dementia 
Severity 
CDR scale -.757  
Functional 
Capacity 
T-ADLQ -.864  
PFAQ -.748  
IADL scale .769  
Cognitive 
Change 
AD8-Ch -.700  
 
 
Note. TYM-S = Test Your Memory-Spanish Version; MMSE = Mini-Mental State Examination; ACE-R-Ch 
= Addenbrooke’s Cognitive Examination-Revised-Chilean Version; MoCA = Montreal Cognitive 
Assessment; FAB = Frontal Assessment Battery; CDR = Clinical Dementia Rating; T-ADLQ = 
Technology-Activities of Daily Living Questionnaire; PFAQ = Pfeffer Functional Activities Questionnaire; 
IADL = Instrumental Activities of Daily Living; AD8-Ch = Alzheimer’s Disease 8-Chilean Version. 
Pearson correlation coefficient, p < .001. 
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Table 5 
Receiver Operating Characteristic Curves for the TYM-S and Other Cognitive Screening Tests 
 
Comparison Instrument 
Area 
Under 
Curve 
Cut-
Off 
Point 
Sensitivity Specificity (CI 95%) 
Dementia versus 
Control 
TYM-S .963 39 .931 .862 .922; 1.00 
MMSE .974 28 .931 .828 .934; 1.00 
ACE-R-Ch .984 79 .931 .966 .960; 1.00 
MoCA .970 21 .931 .897 .936; 1.00 
FAB .910 15 .862 .793 .837; .983 
MCI versus 
Control 
TYM-S .826 44 .857 .690 .697; .956 
MMSE .867 29 .857 .655 .754; .980 
ACE-R-Ch .901 86 .857 .793 .813; .990 
MoCA .873 24 .929 .0690 .768; .978 
FAB .729 17 .857 .552 .576; .882 
 
Note. MCI = Mild Cognitive Impairment; TYM-S = Test Your Memory-Spanish Version; MMSE = Mini-
Mental State Examination; ACE-R-Ch = Addenbrooke’s Cognitive Examination-Revised-Chilean Version; 
MoCA = Montreal Cognitive Assessment; FAB = Frontal Assessment Battery. 
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Figure 1 
Receiver Operating Characteristic Curves for the TYM-S and Other Cognitive Screening Tests 
 
Dementia Group versus Control Group MCI Group versus Control Group 
 
Figure 1. Receiver operating characteristic (ROC) curves for the TYM-S and other cognitive 
screening tests. TYM-S = Test Your Memory-Spanish Version; MMSE = Mini-Mental State 
Examination; ACE-R-Ch = Addenbrooke’s Cognitive Examination-Revised-Chilean Version; MoCA 
= Montreal Cognitive Assessment; FAB = Frontal Assessment Battery. 
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PRUEBA TU MEMORIA 
 
(TEST YOUR MEMORY - THE TYM TEST-) 
 
 
Por favor, escriba su nombre completo _____________________________________ 
Hoy es, (complete con el día de la semana) ______________ 
 
La fecha de hoy es: (número de día) ____ de (mes) _________de (año) __________ 
 
¿Qué edad tiene usted? _____ años 
 
¿En qué fecha nació? (número de día) ______ / (mes) _________ / año __________ 
 
 
 
POR FAVOR, COPIE A CONTINUACIÓN, EN LA LÍNEA DE ABAJO,  LA SIGUIENTE ORACIÓN: 
 
LOS BUENOS CIUDADANOS SIEMPRE USAN ZAPATOS OSCUROS 
 
__________________________________________________________ 
 
POR FAVOR, LEA NUEVAMENTE LA ORACIÓN Y TRATE DE RECORDARLA 
 
 
 
 
¿Quién es el presidente de este país? ______________    _____________ 
 
¿En qué año comenzó el último gobierno militar en este país? _________ 
 
 
 
Operaciones numéricas 
 
20 – 4         = ____ 
16 + 17       = ____ 
8 x 6           = ____ 
4 + 15 – 17 = ____ 
 
 Por favor, escriba 4 animales (de 
cualquier tipo) que comiencen con la 
letra P, como por ejemplo, Pelícano: 
 
1 P____________ 
2 P____________ 
3 P____________ 
4 P____________ 
 
 
 
¿En qué se parecen, o tienen en común, una zanahoria y una papa? ____________________________ 
¿En qué se parecen, o tienen en común, un león y un lobo? __________________________________ 
 
 
RECUERDE: LOS BUENOS CIUDADANOS SIEMPRE USAN ZAPATOS OSCUROS 
Por favor, voltee la hoja. Usted no podrá volver a revisar esta plana. 
    /2 
    /4 
    /3 
    /4 
    /4 
   /10 
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POR FAVOR, UNA LOS CÍRCULOS UNO A UNO PARA FORMAR UNA LETRA (IGNORE LOS 
CUADRADOS) 
 
 
 
DIBUJE EN LA SIGUIENTE CARA DE UN RELOJ TODOS SUS NÚMEROS, DEL 1 AL 12, Y CON LOS 
PUNTEROS INDIQUE LAS 9:20 
 
 
 
SIN VOLTEAR LA HOJA, POR FAVOR ESCRIBA A CONTINUACIÓN LA ORACIÓN QUE USTED COPIÓ 
AL COMIENZO DE ESTA PRUEBA. ESCRIBA TODO LO QUE RECUERDE: 
 
 
 
Completado por el evaluador: 
AYUDA ENTREGADA: NINGUNA/DISCRETA-TRIVIAL/LEVE/MODERADA/MUCHA 
¿LAS RESPUESTAS FUERON ESCRITAS POR EL PACIENTE? SÍ __  NO __ 
 
 TOTAL 
    /6 
    /4 
    /3 
    /5 
        /50 
    /5 
Page 32 of 32
http://mc.manuscriptcentral.com/gps
International Journal of Geriatric Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
